By way of PTI
NEW DELHI: The Medication Controller Normal of India (DCGI) has granted emergency use authorisation to Bharat Biotech’s Covaxin for kids above 12 years with sure stipulations, resources mentioned on Saturday.
The Topic Knowledgeable Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech’s EUA software had really useful granting emergency use approval to Covaxin to be used within the 12-18 years age workforce with sure stipulations.
“The suggestions of the SEC had been evaluated by way of every other professionals committee and then DCGI had sought further knowledge from the company,” a supply mentioned.
The DCGI gave its approval Friday, the supply mentioned.